Aerovate Therapeutics
AVTE
#5850
Rank
$0.59 B
Marketcap
$20.57
Share price
-6.12%
Change (1 day)
7.30%
Change (1 year)

Aerovate Therapeutics (AVTE) Fails to deliver data

Key failure to deliver metrics for Aerovate Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Aerovate Therapeutics (AVTE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Aerovate Therapeutics (AVTE) - since 2021

Volume in USD (price x number of shares), data since 2021

Aerovate Therapeutics (AVTE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$6.74 M-82.78%
2023$39.15 M50.32%
2022$26.04 M589.52%
2021$3.77 M